The University of Minnesota and the pharmaceutical company Glaxo Wellcome have reached a settlement over the AIDS virus drug Ziagen. The settlement requires Glaxo Wellcome to pay royalties for the patented drug developed at the University. Total royalties are expected to exceed 300 million dollars.